Andrew Moshfeghi, MD, MBA

Title(s)Associate Professor of Clinical Ophthalmology
SchoolKeck School of Medicine of Usc
AddressHC4 4900 1450 San Pablo Street
Health Sciences Campus
Los Angeles CA 90033-6103
vCardDownload vCard
    Other Positions
    Title(s)Director of Clinical Trials

    Title(s)Medical Director, USC Roski Eye Institute

    Title(s)Vice Chair for Clinical Affairs, Department of Ophthalmology


    Collapse Biography 
    Collapse Education and Training
    Tulane University School of MedicineMD1999
    University of Miami Graduate School of Business AdministrationMBA- Health Sector Policy and Management2009
    North Shore University Hospital, New York University School of MedicineOphthalmology Residency2003
    University of Miami Bascom Palmer Eye InstituteMedical Retina Fellowship2004
    University of Miami Bascom Palmer Eye InstituteVitreoretinal Surgery & Diseases Fellowship2006
    Collapse Awards and Honors
    American Society of Retina Specialists2015  - 2015ASRS Honor Award
    American Academy of Ophthalmology2013  - 2013AAO Achievement Award
    Castle Connolly Top Doctors2012  - 2015Top Doctors Award
    The Best Doctors in America2009  - 2015Best Doctors Award
    University of Miami Graduate School of Business Administration, Executive MBA Program in Health Sect2009Award of Academic Merit
    University of Miami School of Business Administration Program in Health Sector Policy & Management2007  - 2009Full-Tuition Competitive Scholarship for Executive MBA
    Ronald G Michels Fellowship Foundation2005  - 2006Ronald G. Michels Fellowship Foundation Award
    Tulane University School of Medicine1998  - 1999James H. Allen Award for Excellence in Ophthalmology
    1991  - 1995The University of Chicago Small School Talent Search Scholar

    Collapse Overview 
    Collapse Overview
    Andrew A. Moshfeghi, MD, MBA, earned his medical degree from Tulane University School of Medicine in 1999. Following completion of his residency in ophthalmology, Dr. Moshfeghi attended the prestigious Bascom Palmer Eye Institute for his fellowship training in medial retina and vitreoretinal surgery and diseases. He also graduated from the University of Miami Graduate School of Business Administration with an MBA specializing in Health Sector Policy and Management.

    Dr. Andrew A. Moshfeghi serves as an associate professor of clinical ophthalmology, director of Clinical Trials, and director of the Medical Retina and Surgical Retina Fellowship Programs at USC. He is a recognized expert in diseases of the vitreous, retina, and macula. He formerly served as associate professor of Ophthalmology and medical director at the Bascom Palmer Eye Institute at the University of Miami. Dr. Moshfeghi is a noted vitreoretinal surgeon.

    Dr. Moshfeghi’s research concentrates on evaluation of intraocular pharmacotherapeutics, application of novel ophthalmic imaging techniques, and assessing health care utilization trends.

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States. Sci Rep. 2023 06 09; 13(1):9430. Ludwig CA, Vail D, Al-Moujahed A, Callaway NF, Saroj N, Moshfeghi A, Moshfeghi DM. PMID: 37296124; PMCID: PMC10256775.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy. BMJ Open Ophthalmol. 2023 03; 8(1). Nguyen QD, Moshfeghi AA, Lim JI, Ponomareva E, Chauhan A, Rao R, Sherman S. PMID: 37278412; PMCID: PMC10039992.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2022 Jul; 260(7):2191-2200. O'Fee JR, Juliano J, Moshfeghi AA. PMID: 35192029.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Capillary density and caliber as assessed by optical coherence tomography angiography may be significant predictors of diabetic retinopathy severity. PLoS One. 2022; 17(1):e0262996. Kushner-Lenhoff S, Kogachi K, Mert M, Chu Z, Shahidzadeh A, Palejwala NV, Wolfe J, Itty S, Drenser KA, Capone A, Dugel PU, Moshfeghi AA, Ameri H, Daskivich LP, Wang RK, Kashani AH. PMID: 35081154; PMCID: PMC8791516.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    5. FAILED LASER RETINOPEXY IN A PATIENT UNDERGOING PAZOPANIB THERAPY. Retin Cases Brief Rep. 2021 Nov 01; 15(6):752-755. Lifton J, Chow A, Moshfeghi AA. PMID: 31205141.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Relating Retinal Vascular Oxygen Saturation and Microvasculature Morphology at Progressive Stages of Diabetic Retinopathy. Transl Vis Sci Technol. 2021 05 03; 10(6):4. Auvazian SL, Cano J, Leahy S, Karamian P, Kashani A, Moshfeghi A, Ameri H, Blair NP, Shahidi M. PMID: 34111249; PMCID: PMC8107511.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Increasing Incidence and Prevalence of Common Retinal Diseases in Retina Practices Across the United States. Ophthalmic Surg Lasers Imaging Retina. 2021 01 01; 52(1):29-36. Rosenblatt TR, Vail D, Saroj N, Boucher N, Moshfeghi DM, Moshfeghi AA. PMID: 33471912.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    8. Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical Practice. Clin Ophthalmol. 2020; 14:3651-3659. Moshfeghi A, Garmo V, Sheinson D, Ghanekar A, Abbass I. PMID: 33154625; PMCID: PMC7605957.
      View in: PubMed   Mentions: 8  
    9. Visual Acuity Outcomes in Patients Receiving Frequent Treatment of Neovascular Age-Related Macular Degeneration in Clinical Practice. J Vitreoretin Dis. 2021 May-Jun; 5(3):221-226. Moshfeghi AA, Pitcher JD, Lucas G, Boucher N, Saroj N. PMID: 37006507; PMCID: PMC9979036.
      View in: PubMed   Mentions: 1  
    10. Evaluation of Patients Receiving Intravitreal Antivascular Endothelial Growth Factor for Diabetic Macular Edema in Clinical Practice in the United States. J Vitreoretin Dis. 2021 Mar-Apr; 5(2):108-113. Pitcher JD, Moshfeghi AA, Lucas G, Boucher N, Moini H, Saroj N. PMID: 37009083; PMCID: PMC9979048.
      View in: PubMed   Mentions:
    11. Social Cost of Blindness Due to AMD and Diabetic Retinopathy in the United States in 2020. Ophthalmic Surg Lasers Imaging Retina. 2020 04 01; 51(4):S6-S14. Moshfeghi AA, Lanitis T, Kropat G, Kuznik A, Gibson A, Feng H, Prenner J. PMID: 32348529.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Acute Promyelocytic Leukemia With Sudden Vision Loss. JAMA Ophthalmol. 2020 02 01; 138(2):206-207. Hua HU, Rayess N, Moshfeghi AA. PMID: 31804661.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Digital Nullification of Visual Distortion to Quantify Metamorphopsia: A Pilot Study. Ophthalmic Surg Lasers Imaging Retina. 2019 12 01; 51(1):11-20. Lifton JA, Moshfeghi AA. PMID: 31935298.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Outcomes in Patients with Diabetic Macular Edema Requiring Cataract Surgery in VISTA and VIVID Studies. Ophthalmol Retina. 2020 05; 4(5):481-485. Moshfeghi AA, Thompson D, Berliner AJ, Saroj N. PMID: 31924543.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    15. Elimination of a False-Negative Result With the M-CHARTS Metamorphopsia Assessment Tool Achieved Through Sampling Oblique Axes. Ophthalmic Surg Lasers Imaging Retina. 2019 11 01; 50(11):734-736. Lifton JA, Moshfeghi AA. PMID: 31755973.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITIS. Retina. 2019 Nov; 39(11):2070-2076. Rayess N, Obeid A, Storey PP, Juliano J, Rahimy E, Moshfeghi AA, Garg S, Hsu J. PMID: 30157114.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    17. Thomas A. Swift's Electric Rifle Injuries to the Eye and Ocular Adnexa: The Management of Complex Trauma. Ophthalmol Retina. 2019 03; 3(3):258-269. Moysidis SN, Koulisis N, Rodger DC, Chao JR, Leng T, de Carlo T, Burkemper B, Ediriwickrema LS, George MS, Jiang Y, Bohm KJ, Gulati S, Torres RJ, Meallet MA, Moshfeghi AA, Flynn HW, Mieler WF, Williams GA, Humayun MS, Eliott D. PMID: 31014704.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Outer Retinal Defects Represent a Normal Recovery Pathway Following Internal Limiting Membrane Peeling in Macular Hole Surgery. Ophthalmic Surg Lasers Imaging Retina. 2018 09 01; 49(9):e1-e8. Powers MA, Shields RA, Moshfeghi AA, Moshfeghi DM. PMID: 30222813.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    19. A novel classification of high myopia into anterior and posterior pathologic subtypes. Graefes Arch Clin Exp Ophthalmol. 2018 Oct; 256(10):1847-1856. Ludwig CA, Shields RA, Chen TA, Powers MA, Wilkin Parke D, Moshfeghi AA, Moshfeghi DM. PMID: 30030628.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Ocular Tolerance of Contemporary Electronic Display Devices. Ophthalmic Surg Lasers Imaging Retina. 2018 05 01; 49(5):346-354. Clark AJ, Yang P, Khaderi KR, Moshfeghi AA. PMID: 29772045.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    21. Impact of Cataract Surgery during Treatment with Ranibizumab in Patients with Diabetic Macular Edema. Ophthalmol Retina. 2018 02; 2(2):86-90. Moshfeghi AA, Shapiro H, Lemmon LA, Gune S. PMID: 31047350.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    22. The Epidemiology of Retinopathy of Prematurity in the United States. Ophthalmic Surg Lasers Imaging Retina. 2017 07 01; 48(7):553-562. Ludwig CA, Chen TA, Hernandez-Boussard T, Moshfeghi AA, Moshfeghi DM. PMID: 28728176.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansPHPublic Health
    23. Trends in Hospitalization and Incidence Rate for Syphilitic Uveitis in the United States From 1998 to 2009. Am J Ophthalmol. 2017 Aug; 180:133-141. Albini T, Callaway NF, Pershing S, Wang SK, Moshfeghi AA, Moshfeghi DM. PMID: 28549847.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    24. Quantitative microvascular analysis of retinal venous occlusions by spectral domain optical coherence tomography angiography. PLoS One. 2017; 12(4):e0176404. Koulisis N, Kim AY, Chu Z, Shahidzadeh A, Burkemper B, Olmos de Koo LC, Moshfeghi AA, Ameri H, Puliafito CA, Isozaki VL, Wang RK, Kashani AH. PMID: 28437483; PMCID: PMC5402954.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    25. Evaluation of Visunex Medical's PanoCam(TM) LT and PanoCam(TM) Pro wide-field imaging systems for the screening of ROP in newborn infants. Expert Rev Med Devices. 2016 Aug; 13(8):705-12. Wood EH, Moshfeghi AA, Nudleman ED, Moshfeghi DM. PMID: 27424884.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    26. Widefield OCT Findings of a Patient With Stellate Nonhereditary Idiopathic Foveomacular Retinoschisis. Ophthalmic Surg Lasers Imaging Retina. 2016 08 01; 47(8):774-7. Mandell JB, Kim AY, Shahidzadeh A, Ameri H, Puliafito CA, Moshfeghi AA. PMID: 27548456.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    27. Impaired Retinal Perfusion Resulting From Vitreoretinal Traction: A Mechanism of Retinal Vascular Insufficiency. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):1-11. Kashani AH, Zhang Y, Capone A, Drenser KA, Puliafito C, Moshfeghi AA, Williams GA, Trese MT. PMID: 26985791.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Eye-related Emergency Department Visits in the United States, 2010. Ophthalmology. 2016 Apr; 123(4):917-9. Vaziri K, Schwartz SG, Flynn HW, Kishor KS, Moshfeghi AA. PMID: 26704884; PMCID: PMC4808374.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    29. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VENOUS OCCLUSION. Retina. 2015 Nov; 35(11):2323-31. Kashani AH, Lee SY, Moshfeghi A, Durbin MK, Puliafito CA. PMID: 26457395.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    30. Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration. Am J Med. 2016 Mar; 129(3):292-8. Brilliant MH, Vaziri K, Connor TB, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW, Moshfeghi AA, Moshfeghi DM, Fini ME, McKay BS. PMID: 26524704; PMCID: PMC4841631.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    31. Rates of Reoperation and Retinal Detachment after Macular Hole Surgery. Ophthalmology. 2016 Jan; 123(1):26-31. Vaziri K, Schwartz SG, Kishor KS, Fortun JA, Moshfeghi AA, Smiddy WE, Flynn HW. PMID: 26505804; PMCID: PMC4695225.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    32. Self-Reported Characteristics of Retina Specialists in the United States. Ophthalmology. 2016 Feb; 123(2):438-440. Kim EL, Tran JS, Moshfeghi AA. PMID: 26411837.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Reply: To PMID 25486541. Am J Ophthalmol. 2015 Aug; 160(2):392. Pershing S, Vaziri K, Albini TA, Moshfeghi DM, Moshfeghi AA. PMID: 26187878.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Association Between Growth of Geographic Atrophy and the Complement Factor I Locus. Ophthalmic Surg Lasers Imaging Retina. 2015 Jul-Aug; 46(7):772-4. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, Gregori G, Penha FM, Moshfeghi AA, Luo H, Kang Z, Sadda S, Feuer W, Rosenfeld PJ. PMID: 26247461.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    35. Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment. Ophthalmic Surg Lasers Imaging Retina. 2015 Jun; 46(6):643-8. Gregori NZ, Flynn HW, Schwartz SG, Rosenfeld PJ, Vaziri K, Moshfeghi AA, Fortun JA, Kovach JL, Dubovy SR, Albini TA, Davis JL, Berrocal AM, Smiddy WE. PMID: 26114845.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    36. Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin. Ophthalmology. 2015 Jul; 122(7):1438-51. Witkin AJ, Shah AR, Engstrom RE, Kron-Gray MM, Baumal CR, Johnson MW, Witkin DI, Leung J, Albini TA, Moshfeghi AA, Batlle IR, Sobrin L, Eliott D. PMID: 25886796.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    37. Incidence of postoperative suprachoroidal hemorrhage after glaucoma filtration surgeries in the United States. Clin Ophthalmol. 2015; 9:579-84. Vaziri K, Schwartz SG, Kishor KS, Fortun JA, Moshfeghi DM, Moshfeghi AA, Flynn HW. PMID: 25897196; PMCID: PMC4396511.
      View in: PubMed   Mentions: 15  
    38. Comparison of Geographic Atrophy Growth Rates Using Different Imaging Modalities in the COMPLETE Study. Ophthalmic Surg Lasers Imaging Retina. 2015 Apr; 46(4):413-22. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, Gregori G, Penha FM, Moshfeghi AA, Sadda S, Feuer W, Rosenfeld PJ. PMID: 25970861.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    39. Ambulatory surgery center utilization by vitreoretinal surgeons: 1999-2011. Ophthalmic Surg Lasers Imaging Retina. 2015 Mar; 46(3):355-61. Vaziri K, Moshfeghi DM, Hernandez-Boussard T, Callaway NF, Moshfeghi AA. PMID: 25856823.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Incidence of bleb-associated endophthalmitis in the United States. Clin Ophthalmol. 2015; 9:317-22. Vaziri K, Kishor K, Schwartz SG, Maharaj AS, Moshfeghi DM, Moshfeghi AA, Flynn HW. PMID: 25709395; PMCID: PMC4334336.
      View in: PubMed   Mentions: 21  
    41. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. Am J Ophthalmol. 2015 Mar; 159(3):498-504. Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. PMID: 25486541.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    42. Severe bilateral ischemic retinal vasculitis following cataract surgery. Ophthalmic Surg Lasers Imaging Retina. 2014 Jul-Aug; 45(4):338-42. Nicholson LB, Kim BT, Jardón J, Townsend-Pico W, Santos C, Moshfeghi AA, Albini TA, Eliott D, Sobrin L. PMID: 25127533.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    43. Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina. 2014 Jan-Feb; 45(1):18-31. Garcia Filho CA, Yehoshua Z, Gregori G, Nunes RP, Penha FM, Moshfeghi AA, Zhang K, Feuer W, Rosenfeld PJ. PMID: 24354307.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    44. Differential flow rate of commercially available triamcinolone with and without preservative through small-gauge needles. Ophthalmic Surg Lasers Imaging Retina. 2014 Jan-Feb; 45(1):54-7. Cabrera M, Gonzalez A, Albini TA, Rowaan C, Aguilar M, Lee W, Fortun JA, Moshfeghi AA, Flynn HW, Parel JM. PMID: 24392913.
      View in: PubMed   Mentions: 1     Fields:    
    45. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. Ophthalmology. 2014 Mar; 121(3):693-701. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, Gregori G, Penha FM, Moshfeghi AA, Zhang K, Sadda S, Feuer W, Rosenfeld PJ. PMID: 24289920; PMCID: PMC4015213.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCTClinical Trials
    46. Ocriplasmin: a medical or surgical therapy? Retina. 2013 Nov-Dec; 33(10):2001-2. Duker JS, Moshfeghi AA. PMID: 24113274.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Feasibility of telemedicine in detecting diabetic retinopathy and age-related macular degeneration. Semin Ophthalmol. 2015 Mar; 30(2):81-95. Vaziri K, Moshfeghi DM, Moshfeghi AA. PMID: 24171781.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    48. Fundus findings in chronic granulomatous disease. Ophthalmic Surg Lasers Imaging Retina. 2013 Jul-Aug; 44(4):390-2. Vaziri K, Moshfeghi AA, Moshfeghi DM. PMID: 23799791.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesion. Ophthalmic Surg Lasers Imaging Retina. 2013 Jul-Aug; 44(4):334-43. Kim BT, Schwartz SG, Smiddy WE, Doshi RR, Kovach JL, Berrocal AM, Moshfeghi AA, Fortun JA. PMID: 23883268.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    50. Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina. Ophthalmic Surg Lasers Imaging Retina. 2013 Jul-Aug; 44(4):344-59. Nunes RP, Gregori G, Yehoshua Z, Stetson PF, Feuer W, Moshfeghi AA, Rosenfeld PJ. PMID: 23883530.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    51. Academic productivity and its relationship to physician salaries in the University of California Healthcare System. South Med J. 2013 Jul; 106(7):415-21. Fijalkowski N, Zheng LL, Henderson MT, Moshfeghi AA, Maltenfort M, Moshfeghi DM. PMID: 23820322.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    52. 16 and 24 Gy low-voltage X-ray irradiation with ranibizumab therapy for neovascular age-related macular degeneration: 12-month outcomes. Am J Ophthalmol. 2013 Jun; 155(6):1000-1008.e2. Morales-Canton V, Quiroz-Mercado H, Velez-Montoya R, Zavala-Ayala A, Moshfeghi AA, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. PMID: 23497847.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    53. Eight questions with Dr. Puliafito. Ophthalmic Surg Lasers Imaging Retina. 2013 Jan-Feb; 44(1):103-4. Moshfeghi AA. PMID: 23410818.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. Uveitis, the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT), and intravitreal biologics for ocular inflammation. Am J Ophthalmol. 2012 Sep; 154(3):429-435.e2. Yeh S, Albini TA, Moshfeghi AA, Nussenblatt RB. PMID: 22898344; PMCID: PMC3422772.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    55. 16 Gy low-voltage x-ray irradiation followed by as needed ranibizumab therapy for age-related macular degeneration: 12 month outcomes of a 'radiation-first' strategy. Br J Ophthalmol. 2012 Oct; 96(10):1320-4. Moshfeghi AA, Morales-Canton V, Quiroz-Mercado H, Velez-Montoya R, Zavala-Ayala A, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. PMID: 22895887.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    56. The influence of medical school and residency training program upon choice of an academic career and academic productivity among otolaryngology faculty in the United States of America: our experience of 1433 academic otolaryngologists. Clin Otolaryngol. 2012 Feb; 37(1):58-62. Leng T, Jaben KA, Zheng L, Yang J, Paulus YM, Moshfeghi AA, Maltenfort MG, Campbell PG, Ratliff JK, Moshfeghi DM. PMID: 22433138.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. 24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. Ophthalmic Surg Lasers Imaging. 2012 Jan-Feb; 43(1):20-4. Canton VM, Quiroz-Mercado H, Velez-Montoya R, Lopez-Miranda MJ, Moshfeghi AA, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. PMID: 22251841.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    58. Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis. PLoS One. 2011; 6(12):e28383. Thayil SM, Albini TA, Nazari H, Moshfeghi AA, Parel JM, Rao NA, Karakousis PC. PMID: 22162767; PMCID: PMC3230586.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    59. 16-Gy low-voltage x-ray irradiation followed by as-needed ranibizumab therapy for AMD: 6-month outcomes of a "radiation-first" strategy. Ophthalmic Surg Lasers Imaging. 2011 Nov-Dec; 42(6):460-7. Moshfeghi AA, Canton VM, Quiroz-Mercado H, Velez-Montoya R, Lopez-Miranda MJ, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. PMID: 21830745.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. 16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomes. Ophthalmic Surg Lasers Imaging. 2011 Nov-Dec; 42(6):468-73. Canton VM, Quiroz-Mercado H, Velez-Montoya R, Lopez-Miranda MJ, Moshfeghi AA, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. PMID: 21830747.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    61. Radiation treatment for age-related macular degeneration. Semin Ophthalmol. 2011 May; 26(3):121-30. Silva RA, Moshfeghi AA, Kaiser PK, Singh RP, Moshfeghi DM. PMID: 21609224.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    62. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Semin Ophthalmol. 2011 May; 26(3):139-48. Moshfeghi AA. PMID: 21609227.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    63. Medical school and residency influence on choice of an academic career and academic productivity among neurosurgery faculty in the United States. Clinical article. J Neurosurg. 2011 Aug; 115(2):380-6. Campbell PG, Awe OO, Maltenfort MG, Moshfeghi DM, Leng T, Moshfeghi AA, Ratliff JK. PMID: 21495810.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    64. Medical school and residency influence on choice of an academic career and academic productivity among US neurology faculty. Arch Neurol. 2011 Aug; 68(8):999-1004. Campbell PG, Lee YH, Bell RD, Maltenfort MG, Moshfeghi DM, Leng T, Moshfeghi AA, Ratliff JK. PMID: 21482917.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina. 2011 Apr; 31(4):662-8. Moshfeghi AA, Rosenfeld PJ, Flynn HW, Schwartz SG, Davis JL, Murray TG, Smiddy WE, Berrocal AM, Dubovy SR, Lee WH, Albini TA, Lalwani GA, Kovach JL, Puliafito CA. PMID: 21836400.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    66. The vitreous trap: a simple, surgeon-controlled technique for obtaining undiluted vitreous and subretinal specimens during pars plana vitrectomy. Retina. 2011 Feb; 31(2):426-7; author reply 427. Moshfeghi AA, Albini TA, Kitchens JW, Leng T, Moshfeghi DM. PMID: 21233788.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    67. Declining incidence of neonatal endophthalmitis in the United States. Am J Ophthalmol. 2011 Jan; 151(1):59-65.e1. Moshfeghi AA, Charalel RA, Hernandez-Boussard T, Morton JM, Moshfeghi DM. PMID: 20970776.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    68. Management of ruptured retinal arterial macroaneurysm with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging. 2010 Aug 30; 41 Online:e1-5. Javey G, Moshfeghi AN, Moshfeghi AA. PMID: 21155520.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Pathology of macular foveoschisis associated with degenerative myopia. J Ophthalmol. 2010; 2010. Tang J, Rivers MB, Moshfeghi AA, Flynn HW, Chan CC. PMID: 20814547; PMCID: PMC2931386.
      View in: PubMed   Mentions: 8  
    70. Management of ruptured retinal arterial macroaneurysm with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging. 2010 Jul-Aug; 41(4):1-5. Javey G, Moshfeghi AN, Moshfeghi AA. PMID: 21728252.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    71. Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clin Ophthalmol. 2010 May 25; 4:519-24. Cavalcante LL, Cavalcante ML, Murray TG, Vigoda MM, Piña Y, Decatur CL, Davis RP, Olmos LC, Schefler AC, Parrott MB, Alliman KJ, Flynn HW, Moshfeghi AA. PMID: 20535228; PMCID: PMC2879353.
      View in: PubMed   Mentions: 15  
    72. The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria. Clin Ophthalmol. 2010 Apr 26; 4:211-4. Shirodkar AR, Flynn HW, Alliman K, Lalwani GA, Alabiad C, Moshfeghi AA, Miller D. PMID: 20463786; PMCID: PMC2861925.
      View in: PubMed   Mentions: 1  
    73. Methicillin-resistant Staphylococcus epidermidis isolation from the vitrectomy specimen four hours after initial treatment with vancomycin and ceftazidime. Clin Ophthalmol. 2010 Mar 04; 4:101-4. Javey G, Schwartz SG, Moshfeghi AA, Asrani S, Flynn HW. PMID: 20234775; PMCID: PMC2835531.
      View in: PubMed   Mentions: 3  
    74. Spectral-domain optical coherence tomography appearance of preretinal aggregation of intravitreal antibiotics. Retina. 2010 Jan; 30(1):184-5. Javey G, Albini TA, Moshfeghi AA, Kelly KT, Flynn HW. PMID: 19996824.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    75. Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior. Retina. 2009 May; 29(5):689-98. Moshfeghi AA, Nugent AK, Nomoto H, Sanislo SR, Kitchens JW, Moshfeghi DM. PMID: 19373129.
      View in: PubMed   Mentions: 7     Fields:    Translation:Cells
    76. Posterior juxtascleral injection of anecortave acetate: magnetic resonance and echographic imaging and localization in rabbit eyes. Retina. 2007 Feb; 27(2):247-52. Jockovich ME, Murray TG, Clifford PD, Moshfeghi AA. PMID: 17290209.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    77. Valsalva-like retinopathy following hyperopic laser in situ keratomileusis. Ophthalmic Surg Lasers Imaging. 2006 Nov-Dec; 37(6):486-8. Moshfeghi AA, Harrison SA, Reinstein DZ, Ferrone PJ. PMID: 17152544.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    78. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study. Ophthalmology. 2006 Nov; 113(11):2002.e1-12. Moshfeghi AA, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD, Venkatraman AS. PMID: 17027972.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    79. Surgical management of macular retinoschisis associated with high myopia. Arch Ophthalmol. 2006 Aug; 124(8):1197-9. Scott IU, Moshfeghi AA, Flynn HW. PMID: 16908827.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    80. Micro- and nanoparticulates. Adv Drug Deliv Rev. 2005 Dec 13; 57(14):2047-52. Moshfeghi AA, Peyman GA. PMID: 16298454.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    81. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug; 36(4):331-5. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. PMID: 16156152.
      View in: PubMed   Mentions: 242     Fields:    Translation:Humans
    82. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration. Expert Opin Investig Drugs. 2005 May; 14(5):671-82. Moshfeghi AA, Puliafito CA. PMID: 15926872.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    83. Surgical management of non-metallic and non-magnetic metallic intraocular foreign bodies. Ophthalmic Surg Lasers Imaging. 2005 May-Jun; 36(3):189-96. Soheilian M, Feghi M, Yazdani S, Anisian A, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Moshfeghi AA, Peyman GA. PMID: 15957475.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    84. Indocyanine green angiography findings in sympathetic ophthalmia. Ophthalmic Surg Lasers Imaging. 2005 Mar-Apr; 36(2):163-6. Moshfeghi AA, Harrison SA, Ferrone PJ. PMID: 15792321.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    85. Idiopathic macular hole with extensive subretinal fluid: clinical and optical coherence tomography features before and after surgery. Am J Ophthalmol. 2005 Feb; 139(2):383-6. Kitchens JW, Flynn HW, Moshfeghi AA, Puliafito CA. PMID: 15734018.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    86. Persistent outer retinal defect after successful macular hole repair. Am J Ophthalmol. 2005 Jan; 139(1):183-4. Moshfeghi AA, Flynn HW, Elner SG, Puliafito CA, Gass JD. PMID: 15652846.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    87. Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4A retinopathy of prematurity. Arch Ophthalmol. 2004 Dec; 122(12):1816-8. Moshfeghi AA, Banach MJ, Salam GA, Ferrone PJ. PMID: 15596585.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    88. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol. 2004 Sep; 138(3):489-92. Moshfeghi AA, Scott IU, Flynn HW, Puliafito CA. PMID: 15364241.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    89. Management of magnetic intravitreal foreign bodies in 71 eyes. Ophthalmic Surg Lasers Imaging. 2004 Sep-Oct; 35(5):372-8. Soheilian M, Abolhasani A, Ahmadieh H, Azarmina M, Dehgan MH, Mashavekhi A, Siadat F, Moshfeghi AA, Peyman GA. PMID: 15497547.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    90. Excellent visual outcome and reversal of dragging after lens sparing vitrectomy for progressive tractional stage 4a retinopathy of prematurity retinal detachment. Retina. 2004 Aug; 24(4):615-6. Moshfeghi AA, Awner S, Salam GA, Ferrone PJ. PMID: 15300086.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    91. The effects of scleral buckling on young rabbit eyes. Arch Ophthalmol. 2004 Apr; 122(4):473-6. Moshfeghi AA, Pendergast SD, Hartzer MK, Ferrone PJ. PMID: 15078663.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    92. Management of macular holes that develop after retinal detachment repair. Am J Ophthalmol. 2003 Nov; 136(5):895-9. Moshfeghi AA, Salam GA, Deramo VA, Shakin EP, Ferrone PJ, Shakin JL, Fastenberg DM. PMID: 14597042.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    93. Transpupillary thermotherapy threshold parameters: effect of indocyanine green pretreatment. Retina. 2003 Jun; 23(3):378-86. Peyman GA, Genaidy M, Yoneya S, Men G, Ghahramani F, Kuo PC, Bezerra Y, Nishiyama-Ito Y, Moshfeghi AA. PMID: 12824840.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    94. Mardi Gras eye injury survey, 1998-1999. South Med J. 2000 Nov; 93(11):1083-6. Moshfeghi DM, Moshfeghi AA, Belafsky PC, Kim G, Sheffler M, Fink AJ, Kastl PR. PMID: 11095558.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Threshold power levels for NPe6 photodynamic therapy. Ophthalmic Surg Lasers. 2000 Mar-Apr; 31(2):136-42. Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA. PMID: 10743925.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    96. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies. Ophthalmic Surg Lasers. 1998 Aug; 29(8):663-8. Moshfeghi DM, Peyman GA, Moshfeghi AA, Khoobehi B, Primbs GB, Crean DH. PMID: 9715492.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    97. Fluorescent vesicle angiography with sodium fluorescein and indocyanine green. Ophthalmic Surg Lasers. 1996 Apr; 27(4):279-84. Peyman GA, Moshfeghi DM, Moshfeghi AA, Khoobehi B. PMID: 8705742.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Andrew's Networks
    Concepts (351)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (13)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.